Trials / Completed
CompletedNCT03741231
18FDG-PET in Patients With Melanoma or NSCLC Treated With Immunotherapy
18FluoroDeoxyGlucose-Positron Emission Tomography (PET) in Patients With Melanoma or Non Small Cell Lung Cancer Treated With Immunotherapy
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 70 (actual)
- Sponsor
- University Hospital, Brest · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Study the EFS and OS according to 18FDG PET in patients with melanoma or non small cell lung cancer treated by immunotherapy.
Detailed description
Study EFS in patients with melanoma or NSCLC treated by immunotherapy (anti CTLA4 or anti PDL1) and performed18FDG PET Multicentric retrospective study
Conditions
Timeline
- Start date
- 2018-03-01
- Primary completion
- 2018-06-30
- Completion
- 2018-06-30
- First posted
- 2018-11-14
- Last updated
- 2019-05-06
Locations
3 sites across 1 country: France
Source: ClinicalTrials.gov record NCT03741231. Inclusion in this directory is not an endorsement.